Brinker Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $3.39M | Buy |
7,502
+252
| +3% | +$114K | 0.11% | 192 |
|
|
2020
Q1 | $2.54M | Sell |
7,250
-120
| -2% | -$42.1K | 0.1% | 201 |
|
|
2019
Q4 | $2.73M | Buy |
7,370
+29
| +0.4% | +$10.7K | 0.08% | 232 |
|
|
2019
Q3 | $2.44M | Buy |
7,341
+24
| +0.3% | +$7.99K | 0.08% | 234 |
|
|
2019
Q2 | $2.29M | Sell |
7,317
-71
| -1% | -$22.2K | 0.08% | 237 |
|
|
2019
Q1 | $2.26M | Buy |
7,388
+2,123
| +40% | +$649K | 0.09% | 238 |
|
|
2018
Q4 | $1.22M | Sell |
5,265
-266
| -5% | -$61.8K | 0.05% | 349 |
|
|
2018
Q3 | $1.73M | Buy |
5,531
+2,664
| +93% | +$834K | 0.06% | 335 |
|
|
2018
Q2 | $827K | Sell |
2,867
-814
| -22% | -$235K | 0.03% | 543 |
|
|
2018
Q1 | $921K | Sell |
3,681
-154
| -4% | -$38.5K | 0.04% | 485 |
|
|
2017
Q4 | $915K | Sell |
3,835
-206
| -5% | -$49.2K | 0.04% | 458 |
|
|
2017
Q3 | $898K | Buy |
+4,041
| New | +$898K | 0.04% | 447 |
|
|
2017
Q2 | – | Sell |
-4,129
| Closed | -$823K | – | 676 |
|
|
2017
Q1 | $823K | Sell |
4,129
-456
| -10% | -$90.9K | 0.04% | 426 |
|
|
2016
Q4 | $836K | Buy |
+4,585
| New | +$836K | 0.05% | 338 |
|